One day after the release of the disappointing results from the REDUCE LAP-HF II trial, testing an atrial shunt in heart failure with midrange or preserved ejection fraction (HFmrEF and HFpEF), a ...
Targeted injection of mesenchymal precursor cells (MPCs) into the myocardium is safe but does not reduce recurrent nonfatal decompensated heart failure (HF) events in patients with chronic HF with ...
Heart failure (HF) is one of the leading causes of death and disability worldwide, affecting millions of people and placing an enormous burden on health care systems. The disease occurs when the heart ...
Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...